To understand prescription pattern of HAPID�®

Phase 4

• Conditions: Health Condition 1: M199- Osteoarthritis, unspecified site

• Registration Number: CTRI/2021/07/034607
• Lead Sponsor: Wockhardt Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Any adult patient of Osteoarthritis prescribed with HAPID�® (Un-denatured Type II Collagen and Aflapin) willing to provide written informed consent to share information

Exclusion Criteria

Not Applicable

Study & Design

• Study Type: PMS
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Demographic characteristics ââ?¬â?? Gender, Age, BMI <br/ ><br>2. Clinical characteristics ââ?¬â?? Clinical diagnosis, Kellgren and Lawrence system grade (0-4) <br/ ><br>3. Treatment pattern of HAPIDÃ?® - Duration of HAPID, Type of therapy for Osteoarthritis, Type of Analgesic agents, Concomitant Illness (comorbidity)Timepoint: Day of Visit

Secondary Outcome Measures

Name	Time	Method
ilTimepoint: Nil